Pro-Dex (NASDAQ:PDEX) Share Price Passes Above 200 Day Moving Average – Time to Sell?

Pro-Dex, Inc. (NASDAQ:PDEX)’s share price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $45.52 and traded as high as $68.99. Pro-Dex shares last traded at $66.75, with a volume of 57,942 shares traded.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on PDEX shares. Zacks Research upgraded Pro-Dex to a “hold” rating in a report on Tuesday, May 19th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Pro-Dex in a report on Friday, May 1st. Finally, Ascendiant Capital Markets raised their price objective on shares of Pro-Dex from $56.00 to $70.00 and gave the stock a “buy” rating in a research report on Tuesday, May 12th. One investment analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, Pro-Dex has a consensus rating of “Hold” and a consensus price target of $70.00.

Pro-Dex Trading Down 2.4%

The firm has a market capitalization of $207.89 million, a price-to-earnings ratio of 18.00 and a beta of -0.02. The company has a debt-to-equity ratio of 0.32, a current ratio of 3.67 and a quick ratio of 2.14. The firm’s 50-day simple moving average is $55.49 and its 200 day simple moving average is $46.00.

Pro-Dex (NASDAQ:PDEX) last announced its quarterly earnings data on Thursday, April 30th. The medical instruments supplier reported $1.20 EPS for the quarter, beating the consensus estimate of $0.62 by $0.58. Pro-Dex had a net margin of 16.08% and a return on equity of 22.78%. The business had revenue of $19.95 million during the quarter, compared to the consensus estimate of $17.90 million. Equities analysts expect that Pro-Dex, Inc. will post 3.16 earnings per share for the current year.

Insider Buying and Selling at Pro-Dex

In other Pro-Dex news, CEO Kirk Richard Lee Van, Jr. sold 4,128 shares of the business’s stock in a transaction on Friday, May 22nd. The shares were sold at an average price of $62.36, for a total transaction of $257,422.08. Following the sale, the chief executive officer owned 89,707 shares of the company’s stock, valued at approximately $5,594,128.52. The trade was a 4.40% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 45.90% of the company’s stock.

Institutional Trading of Pro-Dex

Several institutional investors have recently modified their holdings of PDEX. Cubist Systematic Strategies LLC bought a new stake in shares of Pro-Dex in the first quarter worth $170,000. Jane Street Group LLC bought a new stake in shares of Pro-Dex in the first quarter worth $321,000. Geode Capital Management LLC grew its stake in shares of Pro-Dex by 93.2% in the second quarter. Geode Capital Management LLC now owns 51,668 shares of the medical instruments supplier’s stock worth $2,255,000 after purchasing an additional 24,927 shares during the last quarter. JPMorgan Chase & Co. grew its stake in shares of Pro-Dex by 67.7% in the second quarter. JPMorgan Chase & Co. now owns 35,877 shares of the medical instruments supplier’s stock worth $1,566,000 after purchasing an additional 14,479 shares during the last quarter. Finally, New York State Common Retirement Fund acquired a new position in Pro-Dex in the second quarter valued at $105,000. Institutional investors own 15.28% of the company’s stock.

About Pro-Dex

Pro-Dex, Inc is a designer and manufacturer of precision drive systems and fluid management products serving the dental, medical, industrial and energy markets. The company specializes in high-speed, brushless micromotors and controllers, as well as pneumatic and fluid control devices, providing both standard and custom-engineered solutions for original equipment manufacturers.

Its product portfolio includes high-speed dental handpieces, turbine systems, rotary and reciprocating micro-drives, along with integrated fluid delivery systems.